Abstracts - faqs.org

Abstracts

Biological sciences

Search abstracts:
Abstracts » Biological sciences

Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways

Article Abstract:

Certain cytokines, erythropoietin and interleukin-3, keep gamma-IR-induced apoptosis and cell cycle arrest from occurring. Activation of the Jak kinase is necessary and sufficient as a cause. If hematopoietic progenitors are exposed to gamma-irradiation (IR), the result is p-53-dependent apoptosis and a p53-independent G2/M cell cycle arrest. The Jak signaling pathway can be functionally linked to suppression of p53-mediated cell death by cytokine action. Apoptotic and growth arrest that result from DNA damage in hematopoietic cells are altered by certain cytokine-specific signal transduction paths.

Author: Ihle, James N., Cleveland, John L., Zambetti, Gerard P., Quelle, Frederick W., Wang, Demin, Wang, JinLing, Feng, Jian
Publisher: Cold Spring Harbor Laboratory Press
Publication Name: Genes & Development
Subject: Biological sciences
ISSN: 0890-9369
Year: 1998
Genetic aspects, Cell cycle, Cytokines, Erythropoietin, Interleukin-3

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation

Article Abstract:

Yeast two-hybrid methods identified proteins, designated TRADD, that interact with the intracellular region of human TNFR1, a receptor mediating apoptosis or programmed cell death. Overexpression of TRADD in cells has been shown to induce apoptosis and activation of NF-kappaB, suggesting that two signal pathways are triggered. Activation of the crmA gene encoding the expression of 1beta-converting enzyme inhibited TRADD-mediated cell death, but had no effect on NF-kappaB. This suggests that the apoptotic signal pathway is distinct from the pathway signaling NF-kappaB activation.

Author: Hsu, Hailing, Goeddel, David V., Xiong, Jessie
Publisher: Elsevier B.V.
Publication Name: Cell
Subject: Biological sciences
ISSN: 0092-8674
Year: 1995

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Contenders in FasL/TNF death signaling

Article Abstract:

The Fas ligand (FasL) and the tumor necrosis factors (TNFR) induce apoptosis or programmed cell death through interaction with receptors belonging to the TNFR superfamily, which forms the cell death pathway. FasL and TNFR sends signals that activate genes inducing cytoplasmic changes in the cell. The yeast two-hybrid method suggest that FasL and TNFR contain proteins that are homologous to the death domains of Fas and TNFR1. It was also shown that other receptors/reaper such as TRADD, FADD and RIP contains effector domains for apoptosis.

Author: Ihle, James N., Cleveland, John L.
Publisher: Elsevier B.V.
Publication Name: Cell
Subject: Biological sciences
ISSN: 0092-8674
Year: 1995

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Cell death, Cellular signal transduction, Tumor necrosis factor
Similar abstracts:
  • Abstracts: SSEA-1 marks regionally restricted immature subpopulations of embryonic retinal progenitor cells that are regulated by the Wnt signaling pathway
  • Abstracts: Gene activities that mediate increased life span of C. elegans insulin-like signaling mutants. Conservation of the global sex determination gene tra-1 in distantly related nematodes
  • Abstracts: Activation of cytoplasmic trehalase by cyclic-AMP-dependent and cyclic-AMP-independent signalling pathways in the yeast Candida utilis
  • Abstracts: Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway
  • Abstracts: WTI interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.